Company Filing History:
Years Active: 2007-2010
Title: Ulrich Hersel: Innovator in Peptide Conjugates
Introduction
Ulrich Hersel is a notable inventor based in Erlabrunn, Germany. He has made significant contributions to the field of biochemistry, particularly in the development of peptide and peptide mimetic conjugates with integrin-inhibitor properties. His work has implications for treating various medical conditions, including osteoporosis and thrombosis.
Latest Patents
Ulrich Hersel holds 2 patents. His latest patents include innovative compounds designed to act as integrin inhibitors. The first patent describes compounds of the formula (1) B-Q-X, where B is a bioactive cell adhesive mediating molecule. These compounds can be utilized for treating illnesses and deficiencies caused by implants, as well as osteolytic diseases. The second patent also focuses on peptide and peptide mimetic derivatives with integrin-inhibitor properties, emphasizing their potential in medical treatments.
Career Highlights
Ulrich Hersel is associated with Biomet Deutschland GmbH, where he continues to advance research in the field of integrin inhibitors. His work is pivotal in enhancing the integration process of implants and improving biocompatible surfaces in tissue.
Collaborations
He collaborates with notable colleagues, including Joerg Meyer and Berthold Nies, contributing to a dynamic research environment that fosters innovation.
Conclusion
Ulrich Hersel's contributions to the field of peptide conjugates and integrin inhibitors mark him as a significant figure in biochemistry. His innovative patents and collaborative efforts continue to influence medical treatments and advancements in the industry.